Afya

AFYA · NASDAQ

$15.09+$0.18 (+1.21%)TodayMarket closed ·
Prev close $14.91

Latest news

  • Press releaseBusiness Wire

    Afya Limited and YDUQS Participações S.A. Controlling Shareholders Enter Into Voting Commitment Agreement

  • Press releaseBusiness Wire

    Merger Agreement and Other Covenants Entered Into by and Between AFYA LIMITED and YDUQS PARTICIPAÇÕES S.A.

  • Press releaseBusiness Wire

    Afya Limited to Host Afya Day 2026 on October 20th in Rio de Janeiro

  • Press releaseBusiness Wire

    Afya Limited and Yduqs Participações S.A. Enter Into Merger Agreement

  • Press releaseBusiness Wire

    Afya Limited Announces Medical Seats Increase in AFYA Cruzeiro do Sul

  • Press releaseBusiness Wire

    Afya Limited Comments on Recent Public Disclosure Made by Yduqs Participações S.A. Regarding a Potential Business Combination

  • Press releaseBusiness Wire

    Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results

  • Press releaseBusiness Wire

    Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee

  • Press releaseBusiness Wire

    Afya Limited Announces Results of Annual General Meeting Held on June 22, 2026

  • Press releaseBusiness Wire

    Afya Limited Releases 2025 Integrated Report

  • Press releaseBusiness Wire

    Afya Limited (the "Company") Notice of Annual General Meeting of the Company

  • News

    Reported Earlier, Afya Q1 EPS $0.55 Beats $0.54 Estimate, Sales $192.330M Beat $191.870M Estimate

  • Press releaseBusiness Wire

    Afya Limited Announces First-Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Moody's Reaffirmed Afya's AAA.br Rating With a Stable Outlook

  • News

    Afya Q4 Adj. EPS $0.42 Beats $0.37 Estimate, Sales $169.130M Miss $177.120M Estimate

  • Press releaseBusiness Wire

    Afya Limited Announces Fourth Quarter and Twelve Months 2025 Financial Results

  • Press releaseBusiness Wire

    Afya Limited Announces Dividend Distribution of R$307.4 Million

  • News

    Deep Dive Into Afya Stock: Analyst Perspectives (4 Ratings)

  • Press releaseBusiness Wire

    Afya Limited Announces Medical Seats Increase in Afya Abaetetuba

  • NewsAvi Kapoor

    SanDisk To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday

  • Press releaseBusiness Wire

    Afya Announces Changes to Its Board of Directors

  • Press releaseBusiness Wire

    Afya Limited Announces Third Quarter and Nine Months 2025 Financial Results

  • News

    Afya Q3 Adj. EPS $0.38 Beats $0.31 Estimate, Sales $170.420M Beat $168.750M Estimate

  • News

    A Preview Of Afya's Earnings

  • Press releaseBusiness Wire

    Afya Limited Announces Medical Seats Increase in AFYA Faculdade de Ciências Médicas Bragança

  • Press releaseBusiness Wire

    Repurchase of the Series A Perpetual Convertible Preferred Shares and Repayment of Afya Participações S.A. Debentures

  • Press releaseBusiness Wire

    Issuance of Debentures

  • News

    4 Analysts Have This To Say About Afya

  • Press releaseBusiness Wire

    Afya Limited Announces Second-Quarter and First-Half 2025 Financial Results

  • Press releaseBusiness Wire

    Afya Limited Announces a New Share Repurchase Program

  • News

    Afya Limited Announces New Share Repurchase Program For Up To 4M Class A Shares

  • Press releaseBusiness Wire

    Afya Limited Releases 2024 Sustainability Report

  • Press releaseBusiness Wire

    Afya Limited Announces Results of Annual General Meeting Held on June 24, 2025

  • News

    12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

  • NewsAvi Kapoor

    Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.